Skip to content

EXOZ EXOZ Retained Earnings

Retained Earnings at other companies

Gevo logo
GevoGEVO
-$855.62M-4.1%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$6.23B-5.1%
NAG
Niagen Bioscience, Inc. Common StockNAGE
-$158.21M+10.5%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$82.05M+32.0%
Opko Health logo
Opko HealthOPK
-$2.35B-10.0%
Upexi logo
UpexiUPXI
-$282.06M-426%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-5.6%
Enterprise value$76.57M+1.0%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's retained earnings?
EXOZ (EXOZ) reported retained earnings of -$23.47M in Q1 2026.
How has EXOZ's retained earnings changed year-over-year?
EXOZ's retained earnings decreased by 70.1% year-over-year, from -$13.8M to -$23.47M.
What is the long-term trend for EXOZ's retained earnings?
Over 2 years (2023 to 2025), EXOZ's retained earnings has grown at a 86.2% compound annual growth rate (CAGR), from -$6.08M to -$21.1M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.